Doctor profile · Federal record
Dr. Mary Mulcahy, MD
Medical Oncology Physician (CMS: Medical Oncology) · Chicago, IL
- NPI 1306870837
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
675 N Saint Clair St, Galter 21-100
Chicago, IL 606115975
(312) 695-0990
fax (312) 695-1106 - Mailing address
-
680 N Lake Shore Dr, Suite 1000
Chicago, IL 606114546
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 17, 2009
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Illinois #036096205
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306870837. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
151,323
Distinct HCPCS
10
Medicare allowed
$4,022,200
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 34,020 | 57 | $48 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,350 | 54 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 11,840 | 16 | $30 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 11,250 | 14 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,400 | 15 | $3 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 10,362 | 23 | $0 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 8,200 | 63 | $44 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,200 | 18 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 6,960 | 41 | $23 | |
J9041 |
Injection, bortezomib, 0.1 mg | 4,555 | 57 | $5 |
In context: peer comparison
Among 25 peers in Chicago Medical Oncology Physician, average services per provider: 1,025. This provider delivers 148× the peer median.Open Payments
Industry payments received
All-time total
$53
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US INC | 1 | $34.57 | |
| Tempus Ai, INC | 1 | $18.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
314
Patients
106
Total drug cost
$84,107
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prochlorperazine Maleate | Generic | 55 | 32 | $754 |
| Eliquis (Apixaban) | Brand | 48 | 20 | $31,256 |
| Gabapentin | Generic | 33 | 11 | $412 |
| Ondansetron Odt (Ondansetron) | Brand | 29 | 17 | $628 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 27 | 14 | $526 |
| Pantoprazole Sodium | Generic | 20 | 0 | $362 |
| Creon (Lipase/Protease/Amylase) | Brand | 19 | 0 | $48,719 |
| Omeprazole | Generic | 17 | 0 | $90 |
| Oxycodone Hcl | Generic | 15 | 0 | $387 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 14 | 0 | $718 |
Hospital affiliations
Frequently asked questions
What is Dr. Mary Mulcahy's medical specialty?
Dr. Mary Mulcahy practices Medical Oncology Physician in Chicago, IL.
Where does Dr. Mary Mulcahy practice?
Dr. Mary Mulcahy practices at 675 N Saint Clair St, Chicago, IL 606115975. Office phone: 3126950990.
What is Dr. Mary Mulcahy's NPI?
Dr. Mary Mulcahy's National Provider Identifier (NPI) is 1306870837, issued by NPPES.
Does Dr. Mary Mulcahy accept Medicare assignment?
Yes. Dr. Mary Mulcahy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Mulcahy commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.